Did you know it can take an average of 17 years for research evidence to reach clinical practice?
That’s why the Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest and in partnership with National Bank, today announced the launch of a new Mentorship, Capital and Continuation Program (MC2). MC2 will accelerate market-ready healthcare innovations for the aging population from bench to bedside more quickly and efficiently.
The invitation-only program will enable CABHI to identify promising projects in its pipeline that are ready for scale-up. CABHI will also continue to help these projects via collaborative advisory services and additional investment in the innovations.
MC2 will involve two phases:
- Phase 1 will connect selected CABHI-funded project teams with advisors who have industry, clinical, and research expertise to help them develop a strategy to scale, spread and sustain their innovation.
- Based on the results of Phase 1, CABHI will provide financial support, help broker connections to end-users, and offer a suite of services to move innovations towards adoption and procurement.
Through MC2, CABHI is building on the impact of its core programs to offer resources that encourage adoption and procurement of innovations across the healthcare sector in Canada and worldwide.
“The partnership with National Bank on the MC2 program will help to further accelerate market-ready innovations that can improve the quality of life of older adults with dementia and their caregivers,” says Dr. William Reichman, President and CEO of Baycrest. “Through this initiative, CABHI and National Bank will provide additional supports to innovators to enable them to take their market-ready solutions to that next level, and in turn allow for products and services to become more widely accessible to the aging population in Canada, and beyond.”
“National Bank is pleased to be the inaugural partner of CABHI’s MC2 program,” says Louis Vachon, President and CEO, National Bank. “CABHI is a leader in accelerating innovations in aging and brain health. Using our resources and talent to support innovative ideas from entrepreneurs who can drive impactful advancements, in Canada and beyond, is part of our core mission. We also see in this partnership an opportunity to make a difference in the life of a great number of individuals and families, and this always makes us very proud.”
Collaborations and partnerships like MC2 open the doors to enabling Canada’s leading innovators and entrepreneurs to make a difference—by getting their aging and brain health innovations to those who need them as quickly as possible.